The research, conducted by Andrea Miranda-Tena, Francisco J. Sanmartín, and Judith Velasco, took the form of a cross-sectional online survey of 217 young adults aged 18 to 40, recruited through social media, mailing lists, and LGBTIQ+ community organizations across Spain. Of the participants, 144 identified as cisgender heterosexual and 73 as sexual and gender minority, including gay, lesbian, bisexual, transgender, and non-binary individuals. Data were collected between January and April 2025, and the average participant age was 21.5 years. Alongside structured questionnaires, participants answered an open-ended question inviting them to describe any discrimination they had experienced in primary care, responses that were analyzed using reflexive thematic analysis.

The quantitative results were striking. SGM participants scored significantly higher on measures of perceived personal and systemic discrimination. On the single-item measure of personal discrimination in health care, group differences were highly significant, and on the General Discrimination Scale the effect size was moderate to large, with SGM participants reporting markedly greater perceived discrimination. They also reported significantly higher psychological distress on the 12-item General Health Questionnaire, lower trust in physicians on the Trust in Physician Scale, and a greater tendency to delay or avoid seeking medical care they believed they needed. Interestingly, no significant group differences emerged for physical health complaints, and on a multi-item discrimination scale measuring interpersonal treatment in medical settings, the difference between groups did not reach statistical significance.

The study then pushed the analysis further, asking whether discrimination could predict health outcomes statistically. When the three discrimination measures were entered simultaneously into multiple regression models alongside psychological distress and somatic symptoms as outcomes, none of the models reached overall significance. Although perceived discrimination correlated with poorer mental health, lower trust, and delayed care at the bivariate level, it did not emerge as an independent predictor in the multivariate analyses. The authors interpret this cautiously rather than dismissively. Drawing on minority stress theory, they suggest that discrimination may operate less as a discrete, measurable predictor and more as a pervasive background stressor that accumulates over time, interacting with structural and individual-level variables. The modest size of the SGM subgroup may also have limited statistical power, attenuating effects that were visible in simpler analyses.

It is the qualitative accounts that give the numbers their human texture, and they are often uncomfortable reading. Participants described misgendering and the systematic use of incorrect pronouns or former names, with one respondent reporting the repeated use of a name and feminine pronouns that were simply wrong. Others described medical paternalism, with clinicians issuing directives about patients’ private lives while ignoring the care they actually needed. One participant recounted being told how to conduct their personal life as if the physician were a parent, forcing them to argue to prove the clinician wrong. Condescending communication, moralizing remarks about sexual behavior, and outright denial of preventive interventions such as vaccines and PrEP also appeared in the responses.

Some accounts illustrate how bias can translate directly into clinical harm. One participant described living with a Mycoplasma genitalium infection for more than two years while being treated as if it were a urinary infection. Only when they casually mentioned that a former partner was a man did the clinical approach change completely: a full sexually transmitted infection screening was finally performed, the mycoplasma was detected, and treatment began, though symptoms were suspected to have become chronic and no referral to infectious disease specialists was ever made. Another participant, after receiving an HIV diagnosis, was told they should have been more careful and was asked, during an assessment for a monkeypox vaccine, how they were handling their promiscuity. A third requested a publicly funded vaccine protecting against certain STIs and was refused because the doctor assumed a monogamous relationship made it unnecessary; the participant remained unvaccinated.

The thematic analysis also revealed subtler mechanisms. Participants reported gaps in provider knowledge, from unfamiliarity with STI prevention protocols to a partial or complete ignorance of what it means to be a transgender person. Many described deliberate concealment of their sexual orientation or gender identity as a protective strategy, anticipating stigma or discomfort before it even occurred. Weight-based stigma surfaced as well, with one participant describing years in which a skin condition was blamed on their weight until a new doctor finally made the correct diagnosis. Notably, cisgender heterosexual participants also reported negative experiences, particularly weight-related stigma and moral judgement, but they tended to frame these as isolated incidents of unprofessional conduct, whereas SGM participants more often situated similar encounters within a broader pattern of systemic discrimination.

These patterns fit established theoretical frameworks. Minority stress theory conceptualizes discrimination-related stressors as cumulative processes operating through both external events and internal mechanisms such as the anticipation of rejection. The psychological mediation model highlights vigilance, rumination, and avoidance as the pathways through which stigma gets under the skin, shaping how patients approach clinical encounters. The health equity promotion model situates individual experiences within structural contexts, emphasizing how institutionalized discrimination erodes trust, continuity of care, and long-term engagement with health services. Erosion of trust in early adulthood is particularly concerning, the authors note, because it may establish lasting patterns of disengagement from preventive care at precisely the age when such habits form, compounding the disproportionate burden of chronic illness already documented among SGM populations.

The Spanish context makes the findings especially pointed. Previous national data had already signaled trouble: a survey by the Spanish Federation of Lesbians, Gays, Trans, Bisexuals, and Intersex People found that 21.7 percent of transgender respondents accessed primary care only occasionally and 5.8 percent avoided it altogether, citing misgendering, deadnaming, and moral judgements. A 2024 study by the Carlos III Health Institute reported that 80 percent of transgender and non-binary individuals experienced fear or discrimination when accessing primary care. The new study adds a comparative dimension, showing that even within a universal health system in a country recognized internationally for LGBTIQ+ legal protections, SGM young adults remain more wary of their doctors than their peers.

The authors argue that the policy implications are clear. Universal coverage and anti-discrimination law are necessary but insufficient; what is required is affirming, culturally competent care embedded in everyday clinical practice. At the provider level, this means integrating SGM health content into medical education and continuing professional development, following models such as Harvard Medical School’s Sexual and Gender Minority Health Equity Initiative. At the institutional level, it means accountability mechanisms including anonymous reporting systems, equity audits, and systematic patient feedback, alongside visible signals of inclusivity such as gender-neutral language, inclusive intake forms, and affirming signage. Routine collection of sexual orientation and gender identity data could support service planning and the detection of inequities, and the authors stress that meaningful involvement of SGM communities in policy development and program evaluation is essential to ensure reforms are grounded in lived experience.

The study has limitations that temper its conclusions. Its cross-sectional design precludes causal inference, the sample was recruited by convenience and was predominantly White and university-educated, and the qualitative component rested on a limited number of open-text responses that the authors describe as illustrative rather than representative. The SGM subgroup of 73 participants limited statistical power in the multivariate models, and intersectional dimensions such as race, socioeconomic status, and disability could not be examined. Future research, the authors say, should adopt longitudinal and explicitly intersectional designs to capture how discrimination accumulates over time and across overlapping identities. Still, the core message stands: in a country with some of the strongest legal protections in the world, young sexual and gender minority adults still brace for mistreatment when they seek care, and that anticipation alone is enough to erode trust, delay treatment, and widen health disparities. Closing the gap between formal equality and lived experience, the study concludes, will require health systems to actively counteract stigma rather than merely prohibit it.

Subject of Research: Perceived healthcare discrimination, mistrust, and delayed care among sexual and gender minority young adults in Spain

Article Title: Perceived Healthcare Discrimination and Its Impact on Mistrust and Delayed Care Among Sexual and Gender Minority Young Adults in Spain

Article References: Miranda-Tena, A., Sanmartín, F. J., & Velasco, J. (2026). Perceived Healthcare Discrimination and Its Impact on Mistrust and Delayed Care Among Sexual and Gender Minority Young Adults in Spain. Archives of Sexual Behavior. https://doi.org/10.1007/s10508-026-03516-z

Image Credits: AI Generated

DOI: 10.1007/s10508-026-03516-z

Keywords: healthcare discrimination, sexual and gender minority, LGBTIQ+ health, primary care, medical mistrust, delayed care, minority stress, misgendering, psychological distress, Spain, health equity, culturally competent care

Functional gastrointestinal disorders are among the most common diagnoses in paediatric medicine, encompassing conditions such as functional abdominal pain, irritable bowel syndrome, and functional constipation, defined clinically by the Rome IV criteria. Because no structural, biochemical, or inflammatory abnormality explains the symptoms, these disorders have long sat at the intersection of gastroenterology and psychology. Within the biopsychosocial framework that now dominates thinking about FGIDs, the family environment is recognised as a powerful modulator of how a child experiences and expresses symptoms. Yet most previous research compared families of affected children only with healthy families, making it impossible to tell whether elevated parental distress reflected something specific to functional illness or merely the universal stress of raising a child with a chronic gastrointestinal condition.

The Basel team, led by Anna Geser and Sebastian Weber of the Faculty of Medicine at the University of Basel, together with senior authors Margarete Bolten and Eva Unternaehrer, set out to disentangle these possibilities. Between February 2024 and February 2025, they recruited 65 parents of children aged two to twelve years whose FGIDs had been diagnosed according to Rome IV criteria. Two comparison groups were assembled at the same hospital: 62 parents of children with organic gastrointestinal diseases, in which a structural or biological cause had been identified, and 90 parents of healthy children. By including an organic disease control group, the design could separate the specific psychosocial signature of functional illness from the broader caregiving burden of chronic paediatric disease.

Each parent completed three well-validated psychometric instruments. Psychological distress was measured with the four-item Patient Health Questionnaire (PHQ-4), which screens jointly for anxiety and depression. Somatic symptom burden — the tendency to experience and report physical symptoms such as pain, fatigue, or gastrointestinal complaints — was assessed with the eight-item Somatic Symptom Scale (SSS-8). Personality traits were captured with the ten-item Big Five Inventory (BFI-10), from which the researchers extracted neuroticism, the disposition toward emotional instability and negative affect. Because the score distributions were skewed, the team applied non-parametric Kruskal–Wallis tests for initial group comparisons and then refined their estimates using covariate-adjusted negative binomial regression models, reporting incidence rate ratios with appropriate confidence intervals and checking model assumptions with variance inflation factors and Akaike information criteria.

The results were unambiguous. Parents of children with FGIDs scored significantly higher than both comparison groups on all three measures, with differences reaching statistical significance at p < 0.01. In the adjusted regression models, both the organic disease group and the healthy group showed consistently lower scores relative to the FGID group, with incidence rate ratios ranging from 0.31 to 0.77 — a substantial gap that survived correction for demographic and clinical covariates. In practical terms, parental anxiety and depression screening, based on the two subscales of the PHQ-4, yielded the highest positive rates in the FGID group, at roughly 17 percent for anxiety and about 25 percent for depression, well above the levels observed among parents of children with identifiable organic disease.

The neuroticism finding is particularly striking because personality traits are typically considered stable dispositions rather than situational responses. Elevated neuroticism among parents of children with FGIDs cannot plausibly be explained as the transient stress of hospital visits, since parents of children with equally chronic organic gastrointestinal disease did not show the same elevation. One plausible interpretation, consistent with the biopsychosocial model, is that neuroticism and functional illness cluster within families: the same dispositional sensitivity to negative emotion that shapes a parent’s own experience may influence how symptoms are perceived, interpreted, and amplified in the child. Previous research on familial aggregation of pain and somatic complaints has repeatedly suggested that children of parents with high somatic symptom reports tend to report more symptoms themselves, a pattern of modelling and reinforcement that could be especially relevant when the child’s symptoms are, by definition, not explained by observable pathology.

The somatic symptom data add an important mechanistic nuance. In the initial comparisons, parents of children with FGIDs reported a markedly higher somatic symptom burden than either control group. However, when the researchers added psychological distress as an additional covariate, the differences in somatic symptom scores were attenuated. This statistical pattern suggests that the elevated physical symptom reporting among these parents is substantially intertwined with — and possibly mediated by — their anxiety and depressive symptoms. In other words, the parents’ bodily complaints and emotional distress may represent two faces of the same underlying vulnerability, a coupling that mirrors the gut–brain interaction hypothesised to drive the children’s own functional symptoms.

The clinical implications are considerable. If parents of children with FGIDs carry a distinct psychosocial risk profile, then treating the child in isolation may miss a critical lever for recovery. The authors argue that their findings highlight the importance of family-centred approaches to paediatric FGID care, in which parental distress, somatic symptom awareness, and maladaptive illness behaviour are assessed and addressed alongside the child’s symptoms. Screening instruments as brief as the PHQ-4 could feasibly be administered during a routine paediatric gastroenterology visit, identifying families who might benefit from psychological support, psychoeducation about the gut–brain axis, or targeted interventions that reduce parental anxiety about the child’s unexplained symptoms. Such measures could interrupt the feedback loops in which parental concern heightens child symptom focus, which in turn intensifies parental distress.

The study’s cross-sectional design imposes limits on interpretation: elevated parental neuroticism, distress, and somatic symptoms could contribute to the child’s disorder, arise in response to it, or, most likely, reflect bidirectional influences over time. The modest sample sizes — 65, 62, and 90 parents — while adequate for the statistical models employed, leave room for uncertainty in subgroup estimates, and all data derive from self-report questionnaires at a single Swiss tertiary centre. Longitudinal and genetically informed designs will be needed to establish causal direction. Nevertheless, by showing that the parental psychosocial burden in paediatric FGIDs exceeds that seen in organic gastrointestinal disease of comparable chronicity, the Basel team has strengthened the case that functional disorders are genuinely systemic family phenomena. For clinicians confronting a child’s debilitating abdominal pain with no biological explanation, the message is that the family context is not background noise but an active ingredient in the illness — one that rigorous, empathetic assessment can begin to address.

Subject of Research: Parental psychological distress, somatic symptoms and neuroticism in paediatric functional gastrointestinal disorders

Article Title: Parental psychological distress, somatic symptoms and neuroticism in paediatric functional gastrointestinal disorders: comparison with organic and healthy controls

Article References: Geser, A., Weber, S., Légeret, C., Furlano, R., Bolten, M., & Unternaehrer, E. (2026). Parental psychological distress, somatic symptoms and neuroticism in paediatric functional gastrointestinal disorders: comparison with organic and healthy controls. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07681-x

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07681-x

Keywords: functional gastrointestinal disorders, gut-brain interaction, parental distress, somatic symptoms, neuroticism, paediatrics, Rome IV criteria, anxiety, depression, biopsychosocial model, Parental, psychological

The construct at the center of the review is subtle but powerful. Psychological mattering, first articulated by Morris Rosenberg and B.C. McCullough in 1981, describes a person’s need to feel significant to other people—not merely to belong to a group, but to know that specific others notice, rely on, appreciate, and would miss them. Contemporary theory breaks the construct into seven components: importance, attention, dependence, ego extension, noted absence, appreciation, and individualization. The distinction from belonging matters, the authors emphasize. A teenager can feel embedded in a peer group yet still privately doubt that anyone would notice their absence. Mattering is person-focused, anchored to particular figures such as parents, teachers, coaches, or friends, and this anchoring appears to give it unique predictive power over engagement, self-esteem, and emotional regulation.

Developmental science offers a reason to expect mattering to be especially consequential during adolescence. As young people acquire formal operational thinking and abstract reasoning, they also become acutely self-conscious and sensitive to how others evaluate them—phenomena classic theorists described as the imaginary audience and heightened egocentrism. Because adolescents are constantly scanning their social worlds for cues of significance, the authors argue that perceived mattering may function differently, and perhaps more intensely, in this age band than in adulthood. The stakes are considerable. Roughly 15 percent of adolescents experience clinically significant mental health difficulties, and rates of depressive symptoms, anxiety, and loneliness rose after the COVID-19 pandemic disrupted schooling and social connection. Meanwhile, estimates cited in the review suggest that 40 to 60 percent of adolescents feel they do not matter in their communities—an experience strongly associated with negative mental health outcomes.

Methodologically, the review was registered with PROSPERO before data collection began and followed PRISMA reporting guidelines. Eligible studies had to sample adolescents aged ten to nineteen, quantify mattering or antimattering, measure at least one mental health indicator such as depression, anxiety, self-esteem, or stress, recruit from a single social context, and use a cross-sectional or longitudinal design. Grey literature was deliberately excluded to preserve methodological rigor and comparability. Study quality was appraised with the National Institutes of Health tool for observational and cross-sectional research and the Joanna Briggs Institute checklist for analytical cross-sectional studies, with two reviewers rating each study and discrepancies resolved by consensus. Interrater agreement at the screening stage was substantial, with an initial agreement rate of 87 percent and a kappa of .74.

What the nineteen studies revealed was strikingly consistent in direction. Thirteen studies that reported correlations between mattering and mental health found statistically significant associations, with p values ranging from less than 0.001 to less than 0.05. Higher mattering traveled with lower depression in five studies, with correlation coefficients spanning weak to moderate negative relationships, from r = -0.02 to r = -0.42. Combined depression and anxiety composites in three studies showed negative associations between r = -0.16 and r = -0.42. Self-esteem moved the opposite way: five studies documented weak-to-moderate positive correlations between mattering and self-esteem, ranging from 0.19 to 0.52, with the strongest positive relationship, r = 0.54, emerging between mattering and self-esteem in a study using the Antimattering Scale. Wellness and well-being correlations were likewise positive in most analyses, including a strong r = 0.55 between mattering and psychological well-being on Ryff’s scale.

The review also surfaced a curious outlier. One study of at-risk high school students reported moderate-to-strong negative associations between mattering and wellness, with coefficients between -0.28 and -0.55, contradicting the broader literature in which mattering predicts wellness. The original authors did not address the anomaly in their results or discussion, and the review’s authors flag the finding as unexplained and possibly a reporting problem—a cautionary illustration of why methodological transparency matters in this field.

Indeed, measurement emerged as the review’s central technical concern. Mattering was most often assessed with the General Mattering Scale, used in ten studies, followed by Marshall’s Mattering to Others Questionnaire in five. But the provenance of the General Mattering Scale is surprisingly murky: its canonical source is an unpublished 1987 conference presentation by Rosenberg and Marcus that has proved difficult to locate, and several studies adapted the scale for their own purposes without reporting how items were changed or whether validity survived the modification. Similar problems afflicted mental health measures. One research team selected eight of twenty-seven items from the Child Depression Inventory without specifying which items were retained or dropped. Another used only three questions from the Mattering to Others Questionnaire plus a single item from a romantic-relationship subscale, offering no rationale for the deviation. Two studies relied on a single school-mattering item pulled from the CDC’s Youth Risk Behavior Surveillance System, whose psychometric properties for that purpose remain unevaluated.

Depression dominated the outcome landscape, appearing in ten studies, with self-esteem second at seven, followed by anxiety, wellness, life meaning, stress, and suicide ideation. Across the board, higher mattering was associated with reduced stress, anxiety, and suicidal thinking, and with greater wellness and sense of purpose. One study found that depression mediated some of the relationship between mattering and suicide ideation, hinting at a pathway by which feeling insignificant may translate into risk. Still, the review’s authors judged meta-analytic pooling inappropriate: the studies varied in design, relied on underpowered convenience samples of 69 to 1,794 participants without sample-size justification in most cases, modified validated instruments without revalidation, and rarely controlled for confounders. Fifteen of nineteen studies were rated high risk of bias on the NIH sample-size justification criterion alone.

The geographic and contextual reach of the evidence was equally narrow. Fifteen studies were conducted in the United States, three in Canada, and one in China, with sixteen of nineteen using cross-sectional designs and only three following participants over time. Data came overwhelmingly from schools, with a handful of online samples and one youth camp. Family, school, and general contexts received attention, but the settings where adolescents actually spend much of their lives—sports teams, extracurricular clubs, after-school programs—remain essentially unexplored, leaving influential adults such as coaches unstudied as sources of mattering.

The authors conclude that psychological mattering deserves recognition as a promising protective factor, with practical implications for mentorship programs, peer-support initiatives, and inclusive classroom practices that emphasize recognition and social validation. But the path forward, they argue, runs through better science: age-appropriate, psychometrically validated measures of mattering for adolescents; longitudinal and mixed-method designs capable of establishing causal pathways; attention to developmental phenomena like self-consciousness that may inflate or distort mattering reports; and samples diverse enough in culture, socioeconomic status, and gender to support broad generalization. Until that work is done, the safest summary of four decades of evidence is this—when adolescents believe someone would miss them, their minds appear measurably healthier for it, and helping more young people feel that way may be one of the most accessible mental health interventions available.

Subject of Research: Psychological Mattering and Well-being in Adolescents: A Systematic Review

Article Title: Psychological Mattering and Well-being in Adolescents: A Systematic Review

Article References: Williams, R. E., & Blanton, J. E. (2026). Psychological Mattering and Well-being in Adolescents: A Systematic Review. Journal of Child and Family Studies. https://doi.org/10.1007/s10826-026-03372-4

Image Credits: AI Generated

DOI: 10.1007/s10826-026-03372-4

Keywords: Psychological, Mattering, Well-being, Adolescents, Systematic, Review, scientific research

The methodology behind the study reflects a growing consensus in behavioral medicine that obesity treatment outcomes depend heavily on psychological context. Each participant completed six standardized questionnaires: the Self Esteem Scale, which measures global self-worth; the Body Esteem Scale, which captures satisfaction with one’s own body and its specific attributes; the Eating Attitudes Test, a widely used screen for disordered eating attitudes and behaviors; the General Self-Efficacy Scale, which quantifies a person’s belief in their capacity to execute the behaviors needed to manage difficult situations; the Depression Anxiety Stress Scale, which indexes symptoms across those three negative emotional states; and the Short Form Health Survey, the gold-standard instrument for assessing self-reported quality of life and functional health status. Because the patients were enrolled consecutively, the sample offers an unusually unfiltered snapshot of the population that actually presents for treatment, rather than a hand-picked cohort of ideal candidates.

One of the most striking findings concerns treatment preferences. Patients who preferred surgical treatment were more likely to be younger, to have a higher body mass index, and to report greater consumption of highly processed and palatable food. This constellation makes intuitive sense: younger patients with more severe obesity and eating patterns dominated by hyperpalatable, energy-dense products may perceive lifestyle-based interventions as insufficient to the scale of their problem. But it also flags a clinically important subgroup, since heavy consumption of highly processed food and a preference for the most invasive option may coincide with eating behaviors that surgery alone will not resolve. Preoperative psychological profiling is standard practice in bariatric programs, and data like these help clinicians understand what patterns are already present before any scalpel is lifted.

Perhaps the single most consequential number in the study is this: 63.6 percent of participants reported emotional eating, the tendency to eat in response to negative emotions rather than physiological hunger. Notably, emotional eating was correlated with depressive symptoms but not with BMI itself. That dissociation matters. It suggests that emotional eating operates as a psychological phenomenon with its own drivers, not simply as a behavioral manifestation of body weight. A patient with a lower BMI and severe emotional eating may face greater behavioral obstacles to treatment success than a heavier patient without it. If emotional eating is driven partly by depression, then treating mood symptoms could plausibly reduce maladaptive eating behavior, which is precisely the kind of mechanistic hypothesis that baseline profiling studies are designed to generate.

The quality of life data were equally sobering. Both quality of life and self-esteem in this patient population were lower than reference values established for the general population, a finding consistent with the substantial social stigma, functional limitation, and body dissatisfaction that accompany severe obesity. But the researchers went further, running predictive analyses to determine which variables independently explained reduced quality of life. Four factors emerged: higher age, greater body mass index, higher depressive and anxiety symptoms, and lower global self-esteem. The statistical independence of these predictors is important. It means that each contributes unique explanatory power, and that mood symptoms and self-esteem are not merely proxies for how heavy someone is. Two patients with identical BMI values can inhabit radically different subjective worlds depending on their depression, anxiety, and self-worth.

That insight carries direct implications for how obesity programs should be staffed and structured. The authors frame their results explicitly as the first step toward identifying psychological factors that correlate with obesity treatment outcomes, to be combined with follow-up data in order to design a tailored psychological intervention. In their assessment, quality of life, depressive and anxiety symptoms, emotional eating, and global self-esteem appear to be of the greatest importance. This is a deceptively practical list. It tells a program director which domains to measure at intake, which to monitor during treatment, and which to target therapeutically. A patient with depressed mood and low self-esteem may need cognitive behavioral work on self-criticism and mood regulation before behavioral weight management advice can gain traction; a patient dominated by emotional eating may benefit from emotion-regulation training or structured approaches to cue-driven eating.

The study also speaks to a larger shift in how obesity is understood. Over the past decade, leading medical bodies have increasingly framed obesity as a chronic, relapsing disease rather than a failure of willpower, and research on the neural and hormonal regulation of appetite has exposed how powerfully highly processed foods can hijack the brain’s reward circuitry. The Gdansk findings dovetail with this reframing at the psychological level. If nearly two-thirds of patients entering treatment eat in response to emotions, and if mood symptoms independently erode quality of life, then obesity treatment that ignores affective psychology is treating half the disease. Conversely, the study implicitly warns against over-psychologizing: BMI itself remained an independent predictor of quality of life, reminding clinicians that the physical burden of excess weight has consequences that no amount of mood therapy will erase.

Ethically and logistically, the study was designed as part of standard clinical care rather than as an intrusive research protocol. The Independent Bioethics Committee at the Medical University of Gdansk waived the need for separate approval, the study was conducted in accordance with the Declaration of Helsinki, and because the questionnaires were part of routine diagnostics and the data were anonymized, no additional consent was required beyond the consent patients gave for their clinical care. The authors declared no competing interests and received no dedicated funding for the study, though manuscript preparation was supported during a clinical research training program at Harvard Medical School organized by Poland’s Medical Research Agency. The authors also disclosed that they used AI-assisted tools for minor language editing only, with all analyses and interpretations developed by the researchers themselves.

What makes this research potentially viral in its implications is the sheer scale of the problem it addresses. More than a billion people worldwide now live with obesity, and the limitations of pharmacological and surgical treatment, however dramatic recent advances have been, are increasingly clear: medications must often be taken indefinitely, surgery requires lifelong nutritional management, and weight regain remains common across all modalities. Psychological characteristics that predict who struggles and who succeeds could change the calculus entirely. The Gdansk dataset, gathered at the moment of treatment entry, will be joined by longitudinal follow-up data to test whether baseline emotional eating, depression, anxiety, self-esteem, and quality of life actually forecast outcomes, the essential next step from correlation to prediction.

For patients, the message is validating: the struggle with weight is not a character flaw, and the emotional dimensions of obesity are real, measurable, and treatable. For clinicians, it is a roadmap: measure mood, self-esteem, emotional eating, and quality of life at intake, and design interventions that address them directly. For researchers, it is a template for turning a large consecutive clinical sample into a foundation for personalized care. As the authors and their colleagues continue to follow these 572 patients, the field will be watching to see whether the psychological portrait drawn at the threshold of treatment can forecast what happens next, and whether tailored psychotherapy built on that portrait can improve the odds for millions of people whose battle with weight has always been, at least in part, a battle with their own minds.

Subject of Research: Psychological characteristics of patients from obesity treatment program in Gdańsk

Article Title: Psychological characteristics of patients from obesity treatment program in Gdańsk

Article References: Bochenek-Styrylska, P., Grabowski, K., Hoffmann, M., & Kiwnik-Dahm, A. (2026). Psychological characteristics of patients from obesity treatment program in Gdańsk. Discover Psychology. https://doi.org/10.1007/s44202-026-00874-6

Image Credits: AI Generated

DOI: 10.1007/s44202-026-00874-6

Keywords: Psychological, characteristics, patients, obesity, treatment, program, scientific research

The model was introduced most influentially by psychiatrist George Engel, who challenged the dominance of a purely biomedical view in a landmark 1977 paper published in Science. A biological account can describe genetic susceptibility, neural circuitry, neurotransmitter systems, inflammation or the effects of medication, but it cannot by itself explain why the same diagnosis unfolds differently in different people. Engel proposed that clinicians should evaluate illness across interacting levels: the body, the mind and the social environment. In psychiatry, this means that a diagnosis such as major depression, schizophrenia or bipolar disorder should not be treated as an isolated biological event. The symptoms may be real and measurable, but their onset, severity, persistence and response to treatment can also depend on trauma, relationships, housing, work, culture, stress, access to care and the meanings patients assign to their experiences.

That broader view is supported by research on the social determinants of mental health. The editorial points to evidence associating employment with less severe symptoms among people with schizophrenia and bipolar disorder, racial segregation with depression and psychotic disorders, and lower educational attainment with major cognitive disorder. Other influences include adverse childhood experiences, unstable housing, food insecurity, neighborhood violence, natural disasters, painful or disabling medical conditions and a lack of supportive relationships. These factors do not operate as simple one-to-one causes. Rather, they can alter exposure to stress, constrain coping options, affect sleep and physical health, reduce access to treatment or intensify feelings of threat and hopelessness. A patient’s psychological processes also matter: emotion regulation, patterns of interpretation and coping strategies can influence whether stress produces transient distress, persistent symptoms or relapse.

One technical concept that helps explain these interactions is allostatic load, the cumulative physiological burden produced by repeated or chronic stress. Stress-response systems involving the hypothalamus, pituitary gland and adrenal glands can be adaptive in the short term, mobilizing energy and attention during danger. When activated persistently, however, these systems may contribute to dysregulated cortisol patterns, sleep disruption, metabolic changes, inflammatory signaling and impaired cognitive or emotional regulation. Allostatic load is not a single psychiatric mechanism and cannot explain every disorder, but it illustrates why social adversity can become biologically embedded. A person living with violence, financial insecurity or isolation may experience psychological stress and physiological strain simultaneously. If clinicians focus only on symptom counts, they may miss the conditions that continue to drive illness after a medication has reduced symptoms.

The consequences are especially serious for risk assessment. Two people may carry the same diagnosis and receive identical medication regimens yet face very different risks of suicide, relapse, hospitalization, disability or premature death. One may have stable housing, reliable transportation, supportive family members and a job that provides structure; the other may be isolated, unable to afford food, exposed to violence and preparing to lose access to treatment. Medication history alone cannot capture those differences. A biopsychosocial formulation is a structured explanation of how biological vulnerabilities, psychological responses and social circumstances combine in a particular patient. It can reveal why a crisis occurred now, identify practical barriers to recovery and guide interventions that extend beyond pharmacology, including psychotherapy, family work, housing support, social services and safety planning.

The authors argue that training should begin by restoring curiosity about the person behind the diagnosis. Rather than opening every interview with a rapid review of diagnostic symptoms, residents could first ask questions that establish the patient’s world: Who is most important in your life? Where do you live, and with whom? How do you spend your days? What gives you pleasure? These questions are not a replacement for evaluating hallucinations, mood episodes, substance use, cognition, trauma or suicide risk. They are a way to place those symptoms in context and communicate that the clinician is interested in more than whether a patient meets criteria in a diagnostic manual. The approach may also strengthen the therapeutic alliance, because patients are more likely to feel recognized as individuals rather than processed as collections of symptoms.

A complete psychosocial history, the editorial says, should examine financial, educational, occupational and housing stress; relationships and practical support; trauma; exposure to violence; legal concerns; cultural identity; and the patient’s own explanation of illness. Clinicians should ask about loneliness and social isolation, which have been associated with depression, anxiety, dementia and multiple physical illnesses. They should also identify obstacles that can determine whether a treatment plan is realistic: transportation, insurance coverage, caregiving responsibilities, language, digital access and the availability of someone who can help during a crisis. One particularly useful question is “Why now?” A psychiatric disorder may have been present for years, while the immediate reason for seeking care may be a lost job, a breakup, eviction, family conflict, worsening medical illness or the sudden disappearance of a support system. Understanding that trigger can point directly toward an effective intervention.

The editorial also highlights a tension between formal educational requirements and the hidden curriculum of clinical practice. Accreditation standards for psychiatric residents require them to identify biological, psychosocial and developmental factors, integrate those factors into a comprehensive formulation and use multiple conceptual models. The American Board of Psychiatry and Neurology expects trainees to obtain social, cultural, racial and ethnic histories, while broader medical competencies emphasize incorporating social determinants into clinical reasoning. Yet residents learn not only from lectures and examinations. They learn from what supervising physicians ask, document and prioritize in real encounters. If attending psychiatrists spend most of their time discussing neural mechanisms, medication adjustments and discharge logistics, trainees may conclude that psychosocial information is secondary, regardless of what official standards say. The authors warn that digital documentation systems and artificial-intelligence tools could intensify this problem if they make it easier to summarize symptoms than to understand a patient’s lived circumstances.

Training therefore needs to teach not merely the collection of psychosocial facts, but the mechanisms connecting those facts to illness and treatment. In supervision, residents could be asked to explain how a patient’s biological predisposition interacts with stress exposure, beliefs, behavior, relationships and available resources. A case formulation might consider how insomnia worsens emotional regulation, how fear of stigma prevents treatment, how medication side effects threaten employment, or how housing instability makes adherence difficult. Residents could then develop treatment plans spanning pharmacotherapy, psychotherapy and social interventions, while reassessing how the system changes over time. The authors acknowledge that efficiency matters and that structured assessments are essential for safety, but argue that structure should support—not replace—clinical thinking. Engel’s challenge remains relevant nearly five decades later: psychiatric disorders do not occur in a vacuum, and effective care requires understanding the person in whom the illness lives.

Subject of Research: The biopsychosocial model in psychiatric training and clinical evaluation

Article Title: Recentering the Biopsychosocial Model in Psychiatric Training

Article References: Morreale, M. K., Balon, R., Beresin, E. V., et al. “Recentering the Biopsychosocial Model in Psychiatric Training.” Academic Psychiatry (2026). Original research page

Image Credits: AI Generated

DOI: 10.1007/s40596-026-02369-x

Keywords: biopsychosocial model, psychiatric training, mental health, social determinants, clinical formulation, psychiatric evaluation, therapeutic alliance, allostatic load